Qixun Chen
Zhejiang Cancer Hospital(CN)Hangzhou Cancer Hospital(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Esophageal and GI Pathology, Lung Cancer Diagnosis and Treatment
Most-Cited Works
- → Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non–Small Cell Lung Cancer(2024)291 cited
- → Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma(2014)268 cited
- → Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?(2012)79 cited
- → Prognostic Significance of Positive Circumferential Resection Margin in Esophageal Cancer: A Systematic Review and Meta-Analysis(2013)56 cited
- → Neoadjuvant Osimertinib for Resectable EGFR -Mutated Non–Small Cell Lung Cancer(2025)40 cited
- → Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy(2015)36 cited
- → Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma(2016)28 cited
- → Home enteral nutrition's effects on nutritional status and quality of life after esophagectomy.(2019)27 cited
- → Crosstalk between the gut microbiome and clinical response in locally advanced thoracic esophageal squamous cell carcinoma during neoadjuvant camrelizumab and chemotherapy(2022)23 cited
- → Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer(2021)21 cited